Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement
β Scribed by J. J. Boonstra; L.B. Koppert; B.P. Wijnhoven; H.W. Tilanus; H. Van Dekken; T.C.K. Tran; A. Van der Gaast
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 132 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Lymph node metastasis is a definitive prognostic factor; however, perinodal fat tumor invasion has not been fully elucidated. ## Methods: Periesophageal nodes and the surrounding fibrofatty tissue obtained from 131 patients who underwent esophagectomy were examined. ## Results: O
## BACKGROUND. Surgery remains the treatment of choice for patients with esophageal squamous cell carcinoma (SCC), but survival rates have not improved over the past decades. The objective of this study was to evaluate the effect of multimodal therapy on resectability, on the overall and on diseas
## BACKGROUND. Patients with locoregional carcinoma of the esophagus or gastroesophageal junction have a poor survival rate after surgery. Preoperative chemotherapy or chemoradiotherapy has not improved the outcome for these patients. Our study was designed to assess the feasibility of preoperati
## Abstract ## BACKGROUND Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy. ## METHODS Fortyβthree patients with resec